IT1243343B - Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva - Google Patents
Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attivaInfo
- Publication number
- IT1243343B IT1243343B IT02094690A IT2094690A IT1243343B IT 1243343 B IT1243343 B IT 1243343B IT 02094690 A IT02094690 A IT 02094690A IT 2094690 A IT2094690 A IT 2094690A IT 1243343 B IT1243343 B IT 1243343B
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical composition
- polypeptide
- active substance
- liquid pharmaceutical
- nasal administration
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT02094690A IT1243343B (it) | 1990-07-16 | 1990-07-16 | Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva |
ES90120880T ES2067624T3 (es) | 1989-11-16 | 1990-10-31 | Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal. |
EP90120880A EP0432431B1 (en) | 1989-11-16 | 1990-10-31 | Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
DE9090120880T DE69001991T2 (de) | 1989-11-16 | 1990-10-31 | Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten. |
AT90120880T ATE90572T1 (de) | 1989-11-16 | 1990-10-31 | Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten. |
US07/716,390 US5124315A (en) | 1989-11-16 | 1991-06-17 | Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT02094690A IT1243343B (it) | 1990-07-16 | 1990-07-16 | Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva |
Publications (3)
Publication Number | Publication Date |
---|---|
IT9020946A0 IT9020946A0 (it) | 1990-07-16 |
IT9020946A1 IT9020946A1 (it) | 1992-01-16 |
IT1243343B true IT1243343B (it) | 1994-06-10 |
Family
ID=11174459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT02094690A IT1243343B (it) | 1989-11-16 | 1990-07-16 | Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1243343B (it) |
-
1990
- 1990-07-16 IT IT02094690A patent/IT1243343B/it active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IT9020946A0 (it) | 1990-07-16 |
IT9020946A1 (it) | 1992-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2553992A (en) | Bone-growth-stimulating composition | |
IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
ATE166575T1 (de) | Tramadolsalz enthaltende arzneimittel mit verzögerter wirkstofffreitsetzung | |
AU8199187A (en) | A liquid dosage form for oral administration of a pharmaceutically active substance | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
ZA896149B (en) | Pharmaceutical formulation for the treatment of diabetes mellitus | |
CZ285522B6 (cs) | Farmaceutický prostředek pro snížení koncentrace glukosy v krvi | |
NZ320237A (en) | Stable pharmaceutical forms of administration containing parathormone | |
IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
HU9600376D0 (en) | A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient | |
DE3875108T2 (de) | Physiologisch aktives polypeptid und pharmazeutische komposition. | |
EP0177342A3 (en) | Oral formulation of therapeutic proteins | |
SE8804628A (it) | ||
GB2305606B (en) | Drug delivery composition for the nasal administration of ICAM-1 | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
SE8204873L (sv) | Farmaceutiska preparat, innefattande humant insulin och human c-peptid | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
NO892764D0 (no) | Medikamentell administreringsform for droevtyggere. | |
DE69106892D1 (de) | Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit. | |
IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
IT1243343B (it) | Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva | |
DE69120536T2 (de) | Arzneimittel | |
AU2231688A (en) | Stabilisation of therapeutically active proteins in a pharmaceutical composition | |
SE8204871L (sv) | Farmaceutiska preparat, innefattande humant proinsulin | |
HU9300388D0 (en) | New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |